Rhodia does fit nicely the criteria Solvay identified, including improving its presence in emerging economies, lowering its energy and environmental footprint, and" />
IHS Chemical Week

Chemical Week Magazine :: Viewpoint

Solvay Reinvests

10:47 AM MDT | April 15, 2011

Solvay has lined up its desired chemical reinvestment, using proceeds from the February 2010 sale of its pharma business, with a €3.4 billion ($4.9 billion) cash offer for Rhodia ( p. 8). Rhodia had not turned up much in Solvay deal speculation, which has included just about every European chemical maker in Europe with a market cap below €10 billion. Rhodia does fit nicely the criteria Solvay identified, including improving its presence in emerging economies, lowering its energy and environmental footprint, and...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa